Diastereoselective Synthesis of Fluorocyclopropyl Cabozantinib Analogs and Its Improved in vitro Profile
Our young researchers under Janis Veliks supervision have published a case study which showed that fluorocyclopropane analogue of the anticancer drug cabozantinib shows improved selectivity
